{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:10:37Z","timestamp":1762506637701},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/dad.0000000000000281","type":"journal-article","created":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T16:26:47Z","timestamp":1442680007000},"page":"795-798","source":"Crossref","is-referenced-by-count":29,"title":["BRAF Inhibitor\u2013Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced Melanoma"],"prefix":"10.1097","volume":"37","author":[{"given":"Maria C.","family":"Garrido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlota","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Riveiro-Falkenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Rodriguez-Peralto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":". Improved survival with vemurafenib in melanoma with BRAF V600E mutation.","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":". Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.","volume":"366","author":"Sosman","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":". Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/DAD.0000000000000231","article-title":". Primary cutaneous small-medium CD4 T cell lymphoma occurring during treatment with vemurafenib for advanced melanoma.","volume":"37","author":"Garrido","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R5-11-20210202","first-page":"243","article-title":"A new type of cell inclusion, not parasitic, associated with disseminated granulomatous lesions.","volume":"24","author":"Wolbach","year":"1911","journal-title":"J Med Res"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.humpath.2005.02.017","article-title":". Inflammatory cells in the formation of tumor-related sarcoid reactions.","volume":"36","author":"Kurata","year":"2005","journal-title":"Hum Pathol"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0305-7372(86)90002-2","article-title":"Sarcoid reactions in malignant tumors.","volume":"13","author":"Brincker","year":"1986","journal-title":"Cancer Treat Rev"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/1097-0142(197802)41:2<562::AID-CNCR2820410224>3.0.CO;2-X","article-title":". Epithelioid granulomas associated with Hodgkins disease: clinical correlations in 55 previously untreated patients.","volume":"41","author":"Sacks","year":"1978","journal-title":"Cancer"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2133.1997.19542042.x","article-title":". Malignant melanoma and granulomatosis.","volume":"137","author":"Robert","year":"1997","journal-title":"Br J Dermatol"},{"key":"R10-11-20210202","first-page":"939","article-title":"Case of malignant melanoma associated with a sarcoid reaction.","volume":"38","author":"Tsunoda","year":"2011","journal-title":"J Dermatol"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamadermatol.2013.7919","article-title":". Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma. Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma.","volume":"150","author":"Park","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2011.37.9693","article-title":". Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.","volume":"30","author":"Vogel","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000000281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:50Z","timestamp":1620950450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201510000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000281","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}